TradeFlare's AI research teams analysed GLUE on 9 market nights between April 16, 2026 and July 30, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| July 30, 2026 | BUY | $21.56 | — / — | -30.7% | -36.9% | Positive clinical trial progress and pipeline advancement are ongoing. |
| July 29, 2026 | BUY | $22.04 | — / — | -27.6% | -33.3% | Positive clinical trial updates |
| July 1, 2026 | BUY | $24.20 | — / — | +2.1% | -5.6% | Post-earnings drift signal from scanner. |
| June 30, 2026 | BUY | $23.90 | — / — | -0.6% | -10.9% | Post-earnings drift signal from scanner. |
| May 20, 2026 | HOLD | $17.58 | — / — | +4.0% | -1.8% | Positive clinical trial updates for molecular glue degrader programs. |
| May 15, 2026 | BUY | $18.68 | — / — | +3.6% | -0.2% | No clear bullish catalyst identified in the current market regime. |
| May 14, 2026 | HOLD | $18.96 | — / — | +1.1% | -2.4% | No clear bullish catalyst identified. |
| May 13, 2026 | HOLD | $19.11 | — / — | -1.6% | -9.8% | No clear bullish catalyst identified. |
| April 16, 2026 | BUY | $18.23 | — / $16.95 | +7.9% | -0.1% | Positive clinical trial results |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.